跳至主要内容

Neural Plumbing of Men and Women Are from Mars and Venus Respectively

   While measuring brain activity with magnetic resonance imaging during blood pressure trials, scientists at UCLA found that men and women had opposite responses in the right front area of the insular cortex, a part of the brain integral to the experience of emotions, blood pressure control, and self-awareness. The insular cortex has five main parts (gyri) serving different roles. The researchers found that the blood pressure response in the front right gyrus showed an opposite pattern in men and women, with men showing a greater right-sided activation in the area while the women showed a lower response.

    Neural Plumbing.webp

        “This is such a critical brain area and we hadn’t expected to find such strong differences between men and women’s brains,” said Paul Macey, Ph.D., the study’s lead author. “This region, the front right insula, is involved with stress and keeping heart rate and blood pressure high. It’s possible the women had already activated this region because of psychological stress, so that when they did the physical test in the study, the brain region could not activate any more. However, it’s also possible that this region is wired differently in men and women.”


Our Pharmacodynamics Department is proud of its multiple nervous system models based on anti-depressants, anti-Alzheimer's drugs, sedative-hypnotic and anti-anxiety drugs, analgesics, anti-convulsants, anti-Parkinson's drugs, and anti-schizophrenia drugs. Those models can effectively evaluate Type-1 innovative drugs at the molecular and cellular level, as well as ex vivo, and in vivo.

       

 “We have always thought that the ‘normal’ pattern was for this right front insula region to activate more than other areas during a task that raises blood pressure. However, since most earlier studies were in men or male animals, it looks like this ‘normal’ response was only in men. The healthy response in women seems to be a lower right-sided activation.”

   

        Most studies on differences in brain functions between men and women have looked at psychological performance. In previous studies, the UCLA researchers had seen differences in heart rate and blood brain flow during blood pressure changes in men and women with obstructive sleep apnea and wanted to see if cardiovascular responses in brain areas were different in healthy men and women.

   

        In this study (“Sex Differences in Insular Cortex Gyri Responses to the Valsalva Maneuver”), which appears on Frontiers in Neurology, researchers from the UCLA School of Nursing used the Valsalva maneuver, during which participants breathe hard out through a small tube to raise blood pressure, to measure brain activity as it controls the blood pressure change.

   

        “This raises several questions for us, such as why is there a difference in brain pattern and might it reflect differences in health issues for men and women, particularly in cardiovascular disease variations,” noted Dr. Macey.

   

        To find the answers, further study on this difference will be needed to gain a better understanding of susceptibility to disease, efficacy of drugs, and even the course of normal development among all individuals, not just between men and women.

   

    “We believe that differences in the structure and function of the insula in men and women might contribute to different clinical symptoms in some medical disorders,” pointed out Dr. Macey.

评论

此博客中的热门博文

Medicilon and Binhui Biopharmaceutical Have Reached a Strategic Collaboration to Jointly Draw a New Blueprint for the Development of New Biological Drugs

  On March 18, Medicilon and Binhui Biopharmaceutical (Binui Bio) announced a strategic collaboration.  The two parties will work together to jointly explore the possibilities in cutting-edge fields such as oncolytic viruses, nucleic acid drugs and protein drugs. Gather and Work Together to Create Advantages      Facilitate the Research and Development of Oncolytic Viruses, Nucleic Acids, Proteins and Other Drugs As a one-stop biopharmaceutical comprehensive preclinical R&D service CRO, Medicilon has been developing and accumulating for 20 years, always adhering to the spirit of innovation, and has successfully constructed bi/multi-specific antibodies,  ADCs ,  mRNA vaccines ,  small nucleic acid drugs ,  PROTAC , and  CGT technical service platform  that have helped 421 INDs obtain clinical approval.  It is this outstanding achievement that has earned Medicilon wide recognition in the industry and laid a solid foundation f...

A Nickel-Catalyzed Reductive Alkylation of Aryl Bromides and Chlorides for Sp3-Sp2 Bond Formation

  In 2012, a nickel-catalyzed reductive alkylation method of aryl bromides and chlorides was reported. Under the optimized conditions, a variety of aryl and vinyl bromides as well as active aryl chloride can be reductively coupled with alkyl bromides in high yields. The protocols were highly functional-group tolerant and the reactions were not air or moisture sensitive. The reaction showed different chemoselectivity than conventional cross-coupling reactions. Substrates bearing both anelectrophilic and nucleophilic carbon resulted in selective coupling at the electrophilic carbon (R-X) and no reaction occurred at the nucleophilic carbon (R-[M]). The 2010 Nobel Prize in Chemistry was awarded for the Pd-catalyzed cross-coupling, and in the past decade the progress in cross-coupling has not only had a significant impact on academic research but has also influenced the industrial synthetic application. The transition-metal-catalyzed union of nucleophilic organo-boronic acids with elect...

The Launch Meeting was Held by Medicilon and DAC Biotech of the Contract Research on ADC Preclinical Study

  Chuansha, Shanghai, Nov. 8th, 2019 — Medicilon held the launch meeting with Hangzhou DAC Biotech Co., Ltd to initiate the   preclinical study   of the antibody-drug-conjugate (ADC)  DXC005, including the   pharmacology study ,   DMPK study   and the   safety evaluation . Medicilon has previously completed integrated  preclinical research  on ADC drugs cooperating with DAC Biotech and other companies. Two of them has been approved by NMPA and entered Phase I clinical trials. About Hangzhou DAC Biotech Co., Ltd Hangzhou DAC Biotech, Co., Ltd was officially registered in HEDA Area, Hangzhou City, Zhejiang Province, China around the end of Year 2012, and is located nearby the bank of beautiful Qiantang River. The company focuses on developing conjugate of monoclonal antibody and small molecular cytotoxic drug, both of which are banded together with smart linkers. About Antibody-Drug-Conjugate (ADC) ADCs ...